Integrase inhibitors

Results: 73



#Item
51

PDF Document

Add to Reading List

Source URL: www.gilead.com

Language: English - Date: 2013-02-24 13:40:20
52HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS.  ------------------------WARNINGS

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ------------------------WARNINGS

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-04-10 13:31:43
53100 atazanavir B -plausible alternative explanations. Two had elevated levels in the setting of shock and two had elevated levels in the setting of viral hepatitis B activation. [Slide 45]

100 atazanavir B -plausible alternative explanations. Two had elevated levels in the setting of shock and two had elevated levels in the setting of viral hepatitis B activation. [Slide 45]

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-10-04 12:37:38
54FOOD AND DRUG ADMINISTRATION (FDA) CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) ANTIVIRAL DRUGS ADVISORY COMMITTEE MEETING HILTON WASHINGTON, DC/SILVER SPRING; 8727 COLESVILLE ROAD, SILVER SPRING, MARYLAND SEPTEMBER 5,

FOOD AND DRUG ADMINISTRATION (FDA) CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) ANTIVIRAL DRUGS ADVISORY COMMITTEE MEETING HILTON WASHINGTON, DC/SILVER SPRING; 8727 COLESVILLE ROAD, SILVER SPRING, MARYLAND SEPTEMBER 5,

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-08-31 08:26:49
55AIDS InfoNet  www.aidsinfonet.org Fact Sheet Number 106

AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 106

Add to Reading List

Source URL: aidsinfonet.org

Language: English - Date: 2014-04-21 15:36:33
56HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS (raltegravir) Tablets In

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS (raltegravir) Tablets In

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:11:02
57The Division is convening this meeting to solicit the committee’s comments on the following questions:

The Division is convening this meeting to solicit the committee’s comments on the following questions:

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-08-31 08:27:14
58FOOD AND DRUG ADMINISTRATION (FDA) CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) ANTIVIRAL DRUGS ADVISORY COMMITTEE HILTON WASHINGTON, DC/SILVER SPRING; 8727 COLESVILLE ROAD, SILVER SPRING, MARYLAND SEPTEMBER 5, 2007

FOOD AND DRUG ADMINISTRATION (FDA) CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) ANTIVIRAL DRUGS ADVISORY COMMITTEE HILTON WASHINGTON, DC/SILVER SPRING; 8727 COLESVILLE ROAD, SILVER SPRING, MARYLAND SEPTEMBER 5, 2007

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-09-18 16:56:57
59Isentress (raltegravir potassium) tablet label

Isentress (raltegravir potassium) tablet label

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-04-12 17:27:02
60Questions for the Advisory Committee for NDA[removed]

Questions for the Advisory Committee for NDA[removed]

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-09-04 07:18:02